Tel Aviv, Israel-based Aidoc has received FDA approval for its new AI solution that helps triage cervical spine fractures. It’s the company’s third such approval in less than a year, including one in August 2018 and another in May 2019.
The C-spine solution works by using AI to prioritize cases with a suspected fracture, sending them to the top of a radiologist’s worklist.
“With our third FDA clearance, immediately following our PE clearance just weeks ago, there's clearly real momentum behind our solutions,” Michael Braginsky, Aidoc co-founder and CTO, said in a prepared statement. “The key for us was to create a scalable AI engine, a way to rapidly develop high-quality healthcare-grade algorithms. Our C-spine solution tested the limits of what we could do because of the difficulty in detecting spine fractures due to the variability by which they present. We are proud that we were able to release such an accurate solution that is already showing value in clinical practice.”
“We chose to partner with Aidoc because of their scope,” Eyal Zimlichman, MD, chief medical officer of Israel’s Sheba Medical Center, said in the same statement. “I am continuously impressed by the level of comprehensiveness their solutions demonstrate for acute pathologies.”
Michael has more than 16 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.